{"id":816546,"date":"2025-02-24T06:16:01","date_gmt":"2025-02-24T11:16:01","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/haemonetics-to-present-at-raymond-james-46th-annual-institutional-investors-conference\/"},"modified":"2025-02-24T06:16:01","modified_gmt":"2025-02-24T11:16:01","slug":"haemonetics-to-present-at-raymond-james-46th-annual-institutional-investors-conference","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/haemonetics-to-present-at-raymond-james-46th-annual-institutional-investors-conference\/","title":{"rendered":"Haemonetics to Present at Raymond James 46th Annual Institutional Investors Conference"},"content":{"rendered":"<div class=\"xn-newslines\">\n<p class=\"xn-distributor\">PR Newswire<\/p>\n<\/p><\/div>\n<div class=\"xn-content\">\n<p>\n        <span class=\"legendSpanClass\"><br \/>\n          <span class=\"xn-location\">BOSTON<\/span><br \/>\n        <\/span>, <span class=\"legendSpanClass\"><span class=\"xn-chron\">Feb. 24, 2025<\/span><\/span> \/PRNewswire\/ &#8212; Haemonetics Corporation (NYSE: HAE) announced that <span class=\"xn-person\">Chris Simon<\/span>, President and CEO, will participate in a fireside chat with investors at the Raymond James 46th Annual Institutional Investors Conference on <span class=\"xn-chron\">Tuesday, March 4, 2025<\/span> at <span class=\"xn-chron\">2:50 p.m. ET<\/span>.<\/p>\n<div class=\"PRN_ImbeddedAssetReference\" id=\"DivAssetPlaceHolder1\">\n<p>\n          <a href=\"https:\/\/mma.prnewswire.com\/media\/351568\/Haemonetics_Corporation_Logo.html\" target=\"_blank\" rel=\"nofollow\"><br \/>\n            <img decoding=\"async\" src=\"https:\/\/mma.prnewswire.com\/media\/351568\/Haemonetics_Corporation_Logo.jpg\" title=\"\" alt=\"\" \/><br \/>\n          <\/a>\n        <\/p>\n<\/p><\/div>\n<p>The public may access a live webcast of the fireside chat at Haemonetics&#8217; Investor Relations website or at the following link: <a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=4367928-1&amp;h=3749575173&amp;u=https%3A%2F%2Fwsw.com%2Fwebcast%2Frj131%2Fhae%2F1437678&amp;a=https%3A%2F%2Fwsw.com%2Fwebcast%2Frj131%2Fhae%2F1437678\" target=\"_blank\" rel=\"nofollow\">https:\/\/wsw.com\/webcast\/rj131\/hae\/1437678<\/a>. A replay of the recorded webcast will become accessible 12 hours after the event and will be available for 90 days on Haemonetics&#8217; Investor Relations website.<\/p>\n<p>\n        <b>ABOUT HAEMONETICS<\/b>\n      <\/p>\n<p>Haemonetics (NYSE: HAE) is a global healthcare company dedicated to providing a suite of innovative medical products and solutions for customers, to help them improve patient care and reduce the cost of healthcare. Our technology addresses important medical markets: blood and plasma component collection, the surgical suite and hospital transfusion services. To learn more about Haemonetics, visit <a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=4367928-1&amp;h=2525473627&amp;u=http%3A%2F%2Fwww.haemonetics.com%2F&amp;a=www.haemonetics.com\" target=\"_blank\" rel=\"nofollow\">www.haemonetics.com<\/a>.<\/p>\n<p>\n        <b>Investor Contacts:<br \/><\/b><br \/>\n        <span class=\"xn-person\">Olga Guyette<\/span>, Vice President-Investor Relations &amp; Treasury<br \/><span>(781) 356-9763<br \/><\/span><a href=\"mailto:olga.guyette@haemonetics.com\" target=\"_blank\" rel=\"nofollow\">olga.guyette@haemonetics.com<\/a>\u00a0 \u00a0\u00a0<\/p>\n<p>\n        <span class=\"xn-person\">David Trenk<\/span>, Manager-Investor Relations \u00a0 \u00a0 \u00a0<br \/>(203) 733-4987<br \/><a href=\"mailto:david.trenk@haemonetics.com\" target=\"_blank\" rel=\"nofollow\">david.trenk@haemonetics.com<\/a><\/p>\n<p>\n        <b>Media Contact:<\/b><br \/>\n        <br \/>\n        <span class=\"xn-person\">Josh Gitelson<\/span>, Sr. Director-Global Communications\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 <br \/>(781) 356-9776<br \/><a href=\"mailto:josh.gitelson@haemonetics.com\" target=\"_blank\" rel=\"nofollow\">josh.gitelson@haemonetics.com<\/a>\u00a0<\/p>\n<p id=\"PURL\">\n        <img loading=\"lazy\" decoding=\"async\" title=\"Cision\" width=\"12\" height=\"12\" alt=\"Cision\" src=\"https:\/\/c212.net\/c\/img\/favicon.png?sn=NE24901&amp;sd=2025-02-24\" \/> View original content to download multimedia:<a id=\"PRNURL\" rel=\"nofollow\" href=\"https:\/\/www.prnewswire.com\/news-releases\/haemonetics-to-present-at-raymond-james-46th-annual-institutional-investors-conference-302382632.html\" target=\"_blank\">https:\/\/www.prnewswire.com\/news-releases\/haemonetics-to-present-at-raymond-james-46th-annual-institutional-investors-conference-302382632.html<\/a><\/p>\n<p>SOURCE  Haemonetics Corporation<\/p>\n<\/p><\/div>\n<p>    <img decoding=\"async\" alt=\"\" src=\"https:\/\/rt.prnewswire.com\/rt.gif?NewsItemId=NE24901&amp;Transmission_Id=202502240600PR_NEWS_USPR_____NE24901&amp;DateId=20250224\" style=\"border:0px;width:1px;height:1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>PR Newswire BOSTON , Feb. 24, 2025 \/PRNewswire\/ &#8212; Haemonetics Corporation (NYSE: HAE) announced that Chris Simon, President and CEO, will participate in a fireside chat with investors at the Raymond James 46th Annual Institutional Investors Conference on Tuesday, March 4, 2025 at 2:50 p.m. ET. The public may access a live webcast of the fireside chat at Haemonetics&#8217; Investor Relations website or at the following link: https:\/\/wsw.com\/webcast\/rj131\/hae\/1437678. A replay of the recorded webcast will become accessible 12 hours after the event and will be available for 90 days on Haemonetics&#8217; Investor Relations website. ABOUT HAEMONETICS Haemonetics (NYSE: HAE) is a global healthcare company dedicated to providing a suite of innovative medical products and solutions for customers, to help them &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/haemonetics-to-present-at-raymond-james-46th-annual-institutional-investors-conference\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Haemonetics to Present at Raymond James 46th Annual Institutional Investors Conference&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-816546","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Haemonetics to Present at Raymond James 46th Annual Institutional Investors Conference - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/haemonetics-to-present-at-raymond-james-46th-annual-institutional-investors-conference\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Haemonetics to Present at Raymond James 46th Annual Institutional Investors Conference - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PR Newswire BOSTON , Feb. 24, 2025 \/PRNewswire\/ &#8212; Haemonetics Corporation (NYSE: HAE) announced that Chris Simon, President and CEO, will participate in a fireside chat with investors at the Raymond James 46th Annual Institutional Investors Conference on Tuesday, March 4, 2025 at 2:50 p.m. ET. The public may access a live webcast of the fireside chat at Haemonetics&#8217; Investor Relations website or at the following link: https:\/\/wsw.com\/webcast\/rj131\/hae\/1437678. A replay of the recorded webcast will become accessible 12 hours after the event and will be available for 90 days on Haemonetics&#8217; Investor Relations website. ABOUT HAEMONETICS Haemonetics (NYSE: HAE) is a global healthcare company dedicated to providing a suite of innovative medical products and solutions for customers, to help them &hellip; Continue reading &quot;Haemonetics to Present at Raymond James 46th Annual Institutional Investors Conference&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/haemonetics-to-present-at-raymond-james-46th-annual-institutional-investors-conference\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-02-24T11:16:01+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mma.prnewswire.com\/media\/351568\/Haemonetics_Corporation_Logo.jpg\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/haemonetics-to-present-at-raymond-james-46th-annual-institutional-investors-conference\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/haemonetics-to-present-at-raymond-james-46th-annual-institutional-investors-conference\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Haemonetics to Present at Raymond James 46th Annual Institutional Investors Conference\",\"datePublished\":\"2025-02-24T11:16:01+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/haemonetics-to-present-at-raymond-james-46th-annual-institutional-investors-conference\\\/\"},\"wordCount\":217,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/haemonetics-to-present-at-raymond-james-46th-annual-institutional-investors-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/351568\\\/Haemonetics_Corporation_Logo.jpg\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/haemonetics-to-present-at-raymond-james-46th-annual-institutional-investors-conference\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/haemonetics-to-present-at-raymond-james-46th-annual-institutional-investors-conference\\\/\",\"name\":\"Haemonetics to Present at Raymond James 46th Annual Institutional Investors Conference - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/haemonetics-to-present-at-raymond-james-46th-annual-institutional-investors-conference\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/haemonetics-to-present-at-raymond-james-46th-annual-institutional-investors-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/351568\\\/Haemonetics_Corporation_Logo.jpg\",\"datePublished\":\"2025-02-24T11:16:01+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/haemonetics-to-present-at-raymond-james-46th-annual-institutional-investors-conference\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/haemonetics-to-present-at-raymond-james-46th-annual-institutional-investors-conference\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/haemonetics-to-present-at-raymond-james-46th-annual-institutional-investors-conference\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/351568\\\/Haemonetics_Corporation_Logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/351568\\\/Haemonetics_Corporation_Logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/haemonetics-to-present-at-raymond-james-46th-annual-institutional-investors-conference\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Haemonetics to Present at Raymond James 46th Annual Institutional Investors Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Haemonetics to Present at Raymond James 46th Annual Institutional Investors Conference - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/haemonetics-to-present-at-raymond-james-46th-annual-institutional-investors-conference\/","og_locale":"en_US","og_type":"article","og_title":"Haemonetics to Present at Raymond James 46th Annual Institutional Investors Conference - Market Newsdesk","og_description":"PR Newswire BOSTON , Feb. 24, 2025 \/PRNewswire\/ &#8212; Haemonetics Corporation (NYSE: HAE) announced that Chris Simon, President and CEO, will participate in a fireside chat with investors at the Raymond James 46th Annual Institutional Investors Conference on Tuesday, March 4, 2025 at 2:50 p.m. ET. The public may access a live webcast of the fireside chat at Haemonetics&#8217; Investor Relations website or at the following link: https:\/\/wsw.com\/webcast\/rj131\/hae\/1437678. A replay of the recorded webcast will become accessible 12 hours after the event and will be available for 90 days on Haemonetics&#8217; Investor Relations website. ABOUT HAEMONETICS Haemonetics (NYSE: HAE) is a global healthcare company dedicated to providing a suite of innovative medical products and solutions for customers, to help them &hellip; Continue reading \"Haemonetics to Present at Raymond James 46th Annual Institutional Investors Conference\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/haemonetics-to-present-at-raymond-james-46th-annual-institutional-investors-conference\/","og_site_name":"Market Newsdesk","article_published_time":"2025-02-24T11:16:01+00:00","og_image":[{"url":"https:\/\/mma.prnewswire.com\/media\/351568\/Haemonetics_Corporation_Logo.jpg","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/haemonetics-to-present-at-raymond-james-46th-annual-institutional-investors-conference\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/haemonetics-to-present-at-raymond-james-46th-annual-institutional-investors-conference\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Haemonetics to Present at Raymond James 46th Annual Institutional Investors Conference","datePublished":"2025-02-24T11:16:01+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/haemonetics-to-present-at-raymond-james-46th-annual-institutional-investors-conference\/"},"wordCount":217,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/haemonetics-to-present-at-raymond-james-46th-annual-institutional-investors-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/351568\/Haemonetics_Corporation_Logo.jpg","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/haemonetics-to-present-at-raymond-james-46th-annual-institutional-investors-conference\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/haemonetics-to-present-at-raymond-james-46th-annual-institutional-investors-conference\/","name":"Haemonetics to Present at Raymond James 46th Annual Institutional Investors Conference - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/haemonetics-to-present-at-raymond-james-46th-annual-institutional-investors-conference\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/haemonetics-to-present-at-raymond-james-46th-annual-institutional-investors-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/351568\/Haemonetics_Corporation_Logo.jpg","datePublished":"2025-02-24T11:16:01+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/haemonetics-to-present-at-raymond-james-46th-annual-institutional-investors-conference\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/haemonetics-to-present-at-raymond-james-46th-annual-institutional-investors-conference\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/haemonetics-to-present-at-raymond-james-46th-annual-institutional-investors-conference\/#primaryimage","url":"https:\/\/mma.prnewswire.com\/media\/351568\/Haemonetics_Corporation_Logo.jpg","contentUrl":"https:\/\/mma.prnewswire.com\/media\/351568\/Haemonetics_Corporation_Logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/haemonetics-to-present-at-raymond-james-46th-annual-institutional-investors-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Haemonetics to Present at Raymond James 46th Annual Institutional Investors Conference"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/816546","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=816546"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/816546\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=816546"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=816546"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=816546"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}